Female hippocampus vulnerability to environmental stress, a precipitating factor in tau aggregation pathology

Journal of Alzheimer's Disease

Volumn 43, Issue 3, 2015, Pages 763-774

  Sotiropoulos, Ioannis ^a,c,d   Silva, Joana ^c,d   Kimura, Tetsuya ^a,b   Rodrigues, Ana Joao ^c,d   Costa, Patricio ^c,d   Almeida, Osborne F X ^e   Sousa, Nuno ^c,d   Takashima, Akihiko ^a,b  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c UNIVERSITY OF MINHO   (Portugal)

^d UNIVERSITY OF MINHO   (Portugal)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Chaperones; hippocampus; memory; mice; stress; tau aggregates

Indexed keywords

CASPASE 3; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; UNCLASSIFIED DRUG; TAU PROTEIN;

ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL STRESS; FEMALE; HIPPOCAMPUS; HUMAN; IMMUNOHISTOLOGY; MALE; MEMORY DISORDER; MIDDLE AGED; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN AGGREGATION; PROTEIN EXPRESSION; REFERENCE MEMORY; TRANSGENIC MOUSE; WESTERN BLOTTING; AGING; ANIMAL; EPIDEMIOLOGY; MAZE TEST; MEMORY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TAUOPATHY;

AGING; ANIMALS; CASPASE 3; FEMALE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PRECIPITATING FACTORS; TAU PROTEINS; TAUOPATHIES;

EID: 84914706296     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-140693     Document Type: Article

References (60)

1. Iqbal K, Alonso Adel C, Chen S, Chohan O, El-Akkad E, Gong C, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochem Biophys Acta 1739, 198-210.
2. Nasreddine ZS, Loginov M, Clark LN, Lamarche J, Miller BL, Lamontagne A, Zhukareva V, Lee VM-Y,Wilhelmsen K, GeschwindD(1999) From genotype to phenotype:Aclinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L Tau mutation. Ann Neurol 45, 704-715.
3. Kimura T, Fukuda T, Sahara N, Yamashita S, Murayama M, Mizoroki T, Yoshiike Y, Lee B, Sotiropoulos I, Maeda S, Takashima A (2010) Aggregation of detergent-insoluble Tau is involved in neuronal loss but not in synaptic loss. J Biol Chem 285, 38692-386999.
4. Ballatore C, Lee VM-Y, Trojanowski J (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nature Rev Neurosci 8, 663-672.
5. Sotiropoulos I, Cerqueira J, Catania C, Takashima A, Sousa N, Almeida OFX (2008) Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neurosci Biobehav Rev 32, 1161-1173.
6. Launer LJ, Andersen K, Dewey ME, Letenneur l, Ott A, Amaducci LA, Brayne C, Copeland JRM, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A (1999) Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52, 78-84.
7. Bloss E, JanssenW, McEwen B, Morrison JH (2010) Interactive effects of stress and aging on structural plasticity in the prefrontal cortex. J Neurosci 30, 6726-6731.
8. Dalla C, Pitychoutis P, Kokras N, Papadopoulou-Daifoti Z (2011) Sex differences in response to stress and expression of depressive-like behaviours in the rat. Curr Top Behav Neurosci 8, 97-118.
9. Kendler K, Karkowski L, Prescott C (1999) Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156, 837-841.
10. Patchev VK, Almeida OF (1998) Gender specificity in the neural regulation of the response to stress: New leads from classical paradigms. Mol Neurobiol 16, 63-77.
11. Barnes LL,Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA (2005) Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry 62, 685-691.
12. Elgh E, Lindqvist Astot A, Fagerlund M, Eriksson S, Olsson T, Näsman B (2006) Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease. Biol Psychiatry 59, 155-161.
13. Wilson RS, Scherr PA, Schneider JA, Tang Y, Bennett DA (2007) Relation of cognitive activity to risk of developing Alzheimer disease. Neurology 69, 1911-1920.
14. Weiner MF, Vobach S, Olsson K, Svetlik D, Risser RC (1997) Cortisol secretion and Alzheimer's disease progression. Biol Psychiatry 42, 1030-1038.
15. Catania C, Sotiropoulos I, SilvaR, Onofri C, Breen KC, Sousa N, Almeida OFX (2009) The amyloidogenic potential and behavioral correlates of stress-induced amyloidogenesis. Mol Psychiatry 14, 95-105.
16. Green KN, Billings LM, Roozendaal B, McGaugh JL, LaFerla FM (2006) Glucocorticoids increase amyloid-beta and Tau pathology in a mouse model of Alzheimer's disease. J Neurosci 26, 9047-9056.
17. Sotiropoulos I, Catania C, Pinto LG, Silva R, Pollerberg GE, Takashima A, Sousa N, Almeida OFX (2011) Stress acts cumulatively to precipitate Alzheimer's disease-like Tau pathology and cognitive deficits. J Neurosci 31, 7840-7847.
18. Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, De Lucia M, McGowan E, Lewis J, Prihar G, Kim J, Dillmann WH, Browne SE, Hall A, Voellmy R, Tsuboi Y, Dawson TM,Wolozin B, Hardy J, HuttonM(2004) CHIP and Hsp70 regulate Tau ubiquitination, degradation and aggregation. Hum Mol Genet 13, 703-714.
19. Dickey CA, Yue M, Lin WL, Dickson DW, Dunmore JH, Lee WC, Zehr C,West G, Cao S, Clark AMK, Caldwell GA, Caldwell KA, Eckman C, Patterson C, Hutton M, Petrucelli L (2006) Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho-and caspase-3-cleaved Tau species. J Neurosci 26, 6985-6996.
20. Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, Takashima A (2002) Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human Tau. Proc Natl Acad Sci USA 99, 13896-13901.
21. Kimura T, Yamashita S, Fukuda T, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N, Takashima A (2007) Hyperphosphorylated Tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human Tau. EMBO J 26, 5143-5152.
22. YoshiikeY,Yamashita S, Mizoroki T, Maeda S, Murayama M, Kimura T, Sahara N, Soeda Y, Takashima A (2012) Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes. Aging Cell 11, 51-62.
23. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, Almeida OF, Sousa N (2009) The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14, 764-773.
24. Sotiropoulos I, Catania C, Riedemann T, Fry JP, Breen KC, Michaelidis TM, Almeida OFX (2008) Glucocorticoids trigger Alzheimer's disease-like pathobiochemistry in rat neuronal cells expressing human Tau. J Neurochem 107, 385-397.
25. Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of Tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114, 121-130.
26. Weaver C, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of Tau in Alzheimer's disease. Neurobiol Aging 21, 719-727.
27. Conway-Campbell BL, George CL, Pooley JR, Knight DM, Norman MR, Hager GL, Lightman SL (2011) The HSP90 molecular chaperone cycle regulates cyclical transcriptional dynamics of the glucocorticoid receptor and its coregulatory molecules CBP/p300 during ultradian ligand treatment. Mol Endocrinol 25, 944-954.
28. Santa-Maria I, Moreno F, Lim F, Perez M, Avila J (2009) Binding of Hsp90 to Tau promotes a conformational change and aggregation of Tau protein. J Alzheimers Dis 17, 319-325.
29. Luo W, Dou F, Rodina A, Chip S, Kim J, Zhao Q, Moulick K, Aguirre J, Wu N, Greengard P, Chiosis G (2007) Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc Natl Acad Sci USA 104, 9511-9516.
30. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24.
31. Spires-Jones TL, Stoothoff WH, de Calignon A, Jones PB, Hyman BT (2009) Tau pathophysiology in neurodegeneration: A tangled issue. Trends Neurosci 32, 150-159.
32. de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, Spires-Jones TL, Hyman BT (2012) Caspase activation precedes and leads to tangles. Nat 464, 1201-120446.
33. Wang Y, Bierna J, Pickhardt M, Mandelkow E, Mandelkow EM (2007) Stepwise proteolysis liberates Tau fragments that nucleate the Alzheimer-like aggregation of full-length Tau in a neuronal cell model. Proc Natl Acad Sci USA 104, 10252-10257.
34. Miyasaka T, Morishima-Kawashima M, Ravid R, Kamphorst W, Nagashima K, Ihara Y (2001) Selective deposition of mutant Tau in the FTDP-17 brain affected by the P301L mutation. J Neuropathol Exp Neurol 60, 872-884.
35. Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, Gouras GK, Greengard P, Xu H (2003) Chaperones increase association of Tau protein with microtubules. Proc Natl Acad Sci USA 100, 721-726.
36. Sahara N, Murayama M, Mizoroki T, Urushitani M, Imai Y, Takahashi R, Murata S, Tanaka K, TakashimaA(2005) In vivo evidence of CHIP up-regulation attenuating Tau aggregation. J Neurochem 94, 1254-1263.
37. Sahara N, Maeda S, Yoshiike Y, Mizoroki T, Yamashita A, Murayama M, Park JM, Saito Y, Murayama S, Takashima A (2007) Molecular chaperone-mediated Tau protein metabolism counteracts the formation of granular Tau oligomers in human brain. J Neurosci Res 85, 3098-3108.
38. Pratt WB,Morishima Y, Peng HM, Osawa Y (2010) Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage. Exp Biol Med 235, 278-289.
39. Lorenz OR, Freiburger L, Rutz DA, Krause M, Zierer BK, Alvira S, Cuéllar J, Valpuesta JM, Madl T, Sattler M, Buchner J (2014) Modulation of the Hsp90 chaperone cycle by a stringent client protein. Mol Cell 53, 941-953.
40. Kang KI, Meng X, Devin-Leclerc J, Bouhouche I, Chadli A, Cadepond F, Baulieu EE, Catelli MG (1999) The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc Natl Acad Sci USA 96, 1439-1444.
41. Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early Tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol 11, 144-158.
42. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M(2002) Abundant Tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S Tau protein. J Neurosci 22, 9340-9351.
43. Jiao S, Li Z (2011) Nonapoptotic function of BAD and BAX in long-term depression of synaptic transmission. Neuron 70, 758-772.
44. Louneva N, Cohen JW, Han LY, Talbot K,Wilson RS, Bennett DA, Trojanowski JQ, Arnold SE (2008) Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol 173, 1488-1495.
45. MattsonM(2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cel Biol 1, 120-129.
46. Quintanilla R, Matthews-Roberson T, Dolan P, Johnson G (2009) Caspase-cleaved Tau expression induces mitochondrial dysfunction in immortalized cortical neurons. J Biol Chem 284, 18754-18766.
47. Kuchibhotla KV, Wegmann S, Kopeikina KJ, Hawkes J, Rudinskiy N, Andermann ML, Spires-Jones TL, Bacskai BJ, Hyman BT (2014) Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc Natl Acad Sci USA 111, 510-514.
48. Rohn TT, Vyas V, Hernandez-Estrada T, Nichol KE, Christie L, Head E (2008) Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2. J Neurosci 28, 3051-3059.
49. Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, Cirrito JR, Patel TK, Hochgräfe K, Mandelkow EM, Holtzman DM (2014) Neuronal activity regulates extracellular Tau in vivo. J Exp Med 211, 387-393.
50. Lu J, Goula D, Sousa N, Almeida OF (2003) Ionotropic and metabotropic glutamate receptor mediation of glucocorticoidinduced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-D-aspartate receptors. Neuroscience 121, 123-131.
51. Riedemann T, Patchev AV, Cho K, Almeida OF (2010) Corticosteroids: Way upstream. Mol Brain 3, 2.
52. Devi L, Alldred MJ, Ginsberg SD, Ohno M (2010) Sexand brain region-specific acceleration of-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Mol Brain 3, 34.
53. Gandy S, Duff K (2000) Post-menopausal estrogen deprivation and Alzheimer's disease. Exp Gerontol 35, 503-511.
54. Schumacher M, Guennoun R, Ghoumari A, Massaad C, Robert F, El-Etr M, AkwaY, Rajkowski K, Baulieu EE (2007) Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 28, 387-439.
55. Dubal DB, Broestl L, Worden K (2012) Sex and gonadal hormones in mouse models of Alzheimer's disease: What is relevant to the human condition Biol Sex Differ 3, 24.
56. Felicio L, Nelson J, Finch C (1984) Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification. Biol Reprod 31, 446-453.
57. Haisenleder DJ, Schoenfelder AH, Marcinko ES, Geddis LM, Marshall JC (2011) Estimation of estradiol in mouse serum samples: Evaluation of commercial estradiol immunoassays. Endocrinology 152, 4443-4447.
58. Nelson JF, Felicio LS, Randall PK, Sims C, Finch CE (1982) A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol Reprod 27, 327-339.
59. Berenbaum SA, Beltz AM (2011) Sexual differentiation of human behavior: Effects of prenatal and pubertal organizational hormones. Front Neuroendocrinol 32, 183-200.
60. Carroll JC, Rosario ER, Kreimer S, Villamagna A, Gentzschein E, Stanczyk FZ, Pike CJ (2010) Sex differences in-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure. Brain Res 1366, 233-245.